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As part of the development of the database Bgee (a dataBase for Gene Expression Evolution), we annotate and analyse
expression data from different types and different sources, notably Affymetrix data from GEO and ArrayExpress, and
RNA-Seq data from SRA. During our quality control procedure, we have identified duplicated content in GEO and
ArrayExpress, affecting 14% of our data: fully or partially duplicated experiments from independent data submissions,
Affymetrix chips reused in several experiments, or reused within an experiment. We present here the procedure that we





Bgee (a dataBase for Gene Expression Evolution) (1) is a
resource to perform high-throughput and automated
comparisons of gene expression patterns between species.
To this end, it integrates expression data of different types
(ESTs, in situ hybridization, Affymetrix and RNA-Seq data,
as of Bgee release 12), from different species (fruit fly,
human, mouse, Xenopus and zebrafish, as of Bgee release
12). Each data type is analysed using dedicated statistical
tests, to generate present/absent expression calls, and
differential expression calls (overexpression and underex-
pression). These data are then integrated into a homology
framework (relations of homology between organs and
between genes), facilitating the comparison of gene
expression patterns, between and within species, as well
as the study of their evolution.
To date, we have manually curated 15 988 Affymetrix
chips from 1285 experiments, retrieved from Gene
Expression Omnibus (GEO) (2) and ArrayExpress (3). The cur-
ation process includes the following: (i) controlling for sam-
ples ‘normality’ (e.g. no treatments, no diseases, wild type
genotypes); (ii) mapping the chips to anatomical and devel-
opmental ontologies, to determine ‘where and when’
genes are expressed; and (iii) performing quality controls
to remove low-quality and incompatible chips (detailed in
the documentation section of our website; http://bgee.unil.
ch/?page=documentation#AffyQC).
Following improvements in our quality control proced-
ures, we noticed that many chips shared identical values of
quality parameters, which was highly unlikely. After further
examination, we found that these chips were truly
identical. Indeed, it seems to be common practice among
the community to reuse data, especially those used as con-
trols, and to resubmit them to public repositories into new
experiments. Although this might not be an issue when
analysing individual experiments, it is a problem when
performing meta-analyses. Moreover, as this practice is
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not documented, it is misleading for the construction of
secondary databases such as Bgee based on the primary
transcriptome data. We therefore developed a pipeline to
filter for such duplicates.
Bgee release 12 also integrates some RNA-Seq data from
Sequence Read Archive (SRA) (4). In future releases, this is
expected to be the fastest growing data type. Although we
have not yet detected problems of duplicated runs, we
have also built a pipeline to allow their detection. This is
even more important for RNA-Seq data, as we cannot
always store the extremely large run files locally, but we
need to re-download and re-process the data at each new
release. We therefore need not only to check for run file
identity but also to track any change between releases in
the run files that constitute a sample.
Materials and methods
Affymetrix data
We have established a procedure to detect duplicated
Affymetrix data. The procedure is different depending on
whether the raw CEL files or only the processed MAS5 files
(5) are available.
When raw CEL files are available:
(1) Computation of the present/absent MAS5 calls, and
retrieval of the percentage of probesets flagged as
‘present’ for each chip.
(2) Computation of the ‘Inter Quartile Range of average
rank’ (arIQR), a new quality score, which we have
developed. Briefly, it is obtained by ranking all the
probes intensities from a given array, then computing
the average rank for each probeset; arIQR is the inter-
quartile range of the probesets average ranks for a
given array (M. Rosikiewicz and M. Robinson-Rechavi,
unpublished). For the purpose of this article, the
important feature is that it is very unlikely that two
CEL files have the same arIQR.
(3) Generation for each chip of an expression based
unique identifier, by concatenating the percentage
of present probesets and the arIQR score.
(4) Computation of the SHA512 checksum [a cryptographic
hash function, which will provide a unique identifier
for each unique data file (6)] of the CEL files.
(5) Retrieval of the scan dates (second accuracy) from the
CEL files.
If the checksums or the expression based unique identifiers
are equal between two chips, they are likely identical and
are manually checked by curators. The unique identifier
approach might seem redundant to the SHA512 checksum,
but it allowed us to detect duplicates for which the files
were different, because of differences in the CEL file
format used (i.e. CEL format version 3 and 4 generated
with MAS5 and Gene Chip Operating Software, respect-
ively). Although scan date equality is a useful red flag, it
is not sufficient to consider two chips identical and is there-
fore mostly used as a control (two chips can be scanned
together at the same time).
When only processed MAS5 files are available:
(1) Generation of an expression based unique identifier
for each MAS5 file, by concatenating the number of
‘present’ calls, ‘absent’ calls, ‘marginal’ calls and
‘undefined’ calls.
(2) Computation of the SHA512 checksum of the original
MAS5 files.
(3) Standardization of the original files to make them
comparable. Depending on which software was used
[e.g. MAS5, R (7)], the files generated from a same
sample can be slightly different: change of the
header line, change in the order of the probesets,
changes in the values representing the calls. This
limits the use of a checksum for file comparison. We
thus modify all MAS5 files: (i) only the columns of the
probeset identifiers, the signal intensities and the
MAS5 calls are kept; (ii) all lines with non-standard
formats are removed (this notably removes the
header line); (iii) lines are ordered based on the pro-
beset identifiers; (iv) all calls are standardized (‘p’ and
‘present’ in different cases transform to ‘present’; ‘a’
and ‘absent’ in different cases transform to ‘absent’;
‘m’ and ‘marginal’ in different cases transform to
‘marginal’; ‘u’, ‘undefined’ and ‘rp’, in different
cases, transform to ‘undefined’).
(4) Computation of the SHA512 checksum of the standar-
dized files.
If any of the checksums or the expression based unique
identifiers are equal between two chips, they are likely
identical and are manually checked by curators.
The information generated for all CEL files and MAS5
files used in Bgee release 12 are available as supplementary
material (see Supplementary Table S1).
RNA-Seq data
RNA-seq samples are often composed of several runs. As
the run files are re-downloaded and re-processed for each
new release of Bgee, it is important, not only to identify
duplicated run files but also to track changes in the run
composition of samples, between releases. We thus estab-
lished a procedure to uniquely identify run files:
(1) Computation of the SHA512 checksum of the run files.
(2) Retrieval of the size (in bytes) of the run files.
If the checksums are equal between two runs, they are con-
sidered identical. If the sizes are equal, an inspection of the
data is required. This procedure is preliminary, and other
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parameters, such as expression-based unique identifiers,
might be added in the future.
To track potential changes in sample composition, at
each release of Bgee, we store the identifiers of the runs
associated with each sample, and for each run identifier,
the checksum and the size of the related file. We then
compare this information between releases: (i) addition
or deletion of a run file associated with a sample and
(ii) change in the checksum or the size of a run file.
The information generated for the run files used in Bgee
is available as supplementary material (see Supplementary
Table S2).
Results
Identification of duplicated data
Using the procedure described earlier in the text, we have
identified in our data set (Bgee release 12) 1065 groups
of two to four identical Affymetrix chips, reused in one to
four experiments (see Table 1, Supplementary Tables S3
and S4). All files were manually confirmed to be duplicates.
This represents 2173 chips from 111 experiments (13.6%
of our annotated chips and 8.6% of our annotated experi-
ments, respectively). These experiments included from 1 to
340 chips used more than once (see Table 2).
We have identified several typical scenarios explaining
data duplication:
Error in data submission: this is for instance the case
with samples GSM8982 and GSM8979 from experi-
ment GSE591 (8). They are supposed to be two repli-
cates of the expression profiles of 3-week-old female
wild type FVB mice while they are actually identical.
As the experiment includes other wild type samples
with true replicates, this is likely an error. Of note, a
simple checksum comparison of the two files in MAS5
format would have been misleading as the headers of
the files are different (they include the identifier of
the sample). The expression-based identifier and the
checksum of the filtered MAS5 file allowed us to iden-
tify the correspondence between these samples.
Reuse of samples in several experiments: this is for
instance the case in the five experiments, used as
the core data of five papers, GSE9692 (9), GSE26378
(10), GSE8121 (11), GSE13904 (12), and GSE26440 (13).
It appears that over the 101 samples that we have
annotated from these experiments, 72 were reused
several times: 15 were duplicated in four experiments
(60 annotated samples, GSE9692, GSE8121, GSE13904,
GSE26440); three were duplicated in two experiments
(six annotated samples, GSE13904 and GSE26440),
leading these experiments to have a total of 18 sam-
ples in common; yet, three others in two experiments
(six annotated samples, GSE26378 and GSE26440). The
reason is that these experiments reused blood samples
from healthy individuals to be compared with blood
samples from septic shock patients.
Complete duplication of an experiment: all of the 120
samples of the experiment GSE9676 (14) were reused
in the experiment GSE10760 (15). The former experi-
ment studied expression profiles of healthy human
skeletal muscles, whereas the latter compared expres-
sion profiles of muscle samples affected by faciosca-
pulohumeral dystrophy with control samples that
were being reused.
Improvement of the Bgee data set
When files have been manually confirmed to be redundant,
only one representative of the group is kept. When a chip is
duplicated between different experiments, the one that is
part of the experiment with the largest number of remain-
ing chips is kept, as normalization procedures are more
efficient with a larger number of chips. This led us to
remove 1119 chips from our data set (7% of our annotated
chips, see Supplementary Table S4).
In some cases, the information provided about dupli-
cated samples was inconsistent or provided with different
granularity, depending on the focus of the study for which
they were used. For instance, although the samples
GSM322066 and GSM336955 from experiment GSE12826
Table 2. Distribution of pairs of experiments sharing identical chips
Number of shared identical chips 1 2 3 4 5 6–10 11–20 21–50 51–340
Number of experiment pairs 2 5 14 8 3 14 13 3 4
Note that an experiment can be part of several pairs, depending on the number of experiments it shares chips with, and that the four
experiments using duplicated chips within themselves (GSE591, GSE9750, GSE6196 and GSE6490) are not considered.
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(16) and GSE13348 (17) are identical, the first one is sup-
posed to have been obtained from a whole zebrafish em-
bryo and the second one from the brain of a zebrafish
embryo. We have tracked annotation inconsistencies
between identical chips and have corrected them in Bgee.
Discussion
The problem of redundancy has long been identified in
sequence databases [e.g. (18)] but has not been addressed
as far as we know at the level of functional genomics data.
Detecting redundancy in these data can be more compli-
cated than for DNA or protein sequences, but it is import-
ant to allow unbiased meta-analyses and comparisons of
results between conditions or species. For example, dupli-
cated samples might provide a false sense of confidence in
a result, which is in fact only supported by one experimen-
tal data point.
We have implemented different measurements to iden-
tify redundant content, through several iterations, as we
noticed that some of them failed to detect duplicated
Affymetrix chips. For instance, using the SHA512 checksums
failed most of the time to identify duplicated MAS5 files, as
the chip identifier from the source database seems to
be automatically added to the header of these files. Such
duplicates were identified owing to the expression-based
unique identifier approach and to the SHA512 checksums
from the standardized MAS5 files. These two measure-
ments have been so far always congruent but are neverthe-
less both useful. We cannot rule out that two files from
different samples could contain the same number of
expression calls (used to build the expression-based
unique identifier of MAS5 files), or that our filtering step
of the original files could fail to standardize some of them.
Similarly, a third of the CEL files found to be duplicated
were not identified using their SHA512 checksums, but
using their expression-based unique identifiers (all the
other CEL files were identified by both these measure-
ments). This is likely caused by the generation of CEL files,
from a same scan, using different software. The scan date is
in such cases a useful control, which so far always confirmed
the identity revealed by the expression-based unique iden-
tifier. But this scan date is not sufficient to consider two
files as duplicated: in one case, it was identical between
two different CEL files, from a same experiment.
Of note, our pipeline is currently only suitable for the
comparison of MAS5 files on the one hand, and of CEL
files on the other hand, and is not applicable to other file
types. The normalization of a same chip using different
procedures [e.g. gcRMA, RMA (19,20)] leads to slightly dif-
ferent results, which are neither reversible nor comparable.
If two files were generated from a same chip, but using
different normalization procedures, they would not be
identified as duplicates. This is one of the reasons why
raw CEL files are always included preferentially in Bgee,
as the normalization step, irreversibly hiding information,
is not yet performed.
Our pipeline is also only capable of detecting different
files generated from a same assay. It is neither capable of
detecting, for instance, technical replicates, where a same
sample is assayed on different chips, nor is it aimed at
detecting them.
Using this approach, we were able to identify duplicated
content that would have otherwise remained unnoticed.
Indeed, only in a few cases did the authors take care to
link their duplicated samples when submitting their data.
For instance, the samples GSM2334, GSM2335, GSM2336,
from the experiments GSE760 (21) and GSE75 (22), have
the same identifiers and are clearly part of the two experi-
ments. But this represents only 55 groups of duplicated
chips out of 1065 (5%).
In some other cases, the authors mentioned the data
duplication in the full text description of the experiment,
as for the experiment GSE10760 (see example earlier in the
text). Yet this information is not available to automatic
tools; in the majority of cases, the authors did not update
the first experiment submitted to add links to the later one
(i.e. GSE9676 has no link to GSE10760).
Most often, it is nowhere explicitly stated that some sam-
ples are redundant: the identifier of the samples are differ-
ent; the names of the data files are different. By a careful
examination of the experiments descriptions, it might be
possible to realize that the data have been submitted by
the same authors, and that one experiment studied healthy
samples, whereas the other one used healthy samples as a
control. But without a control procedure, such as the one
we have established, this cannot be distinguished from the
case of a laboratory submitting several different experi-
ments related to its research subject.
Conclusion
We have set up procedures to identify duplicated content in
Affymetrix and RNA-Seq data and to track changes in run
composition of samples used in RNA-Seq analyses. We have
discovered that a large number of Affymetrix chips were
actually redundant in the GEO and ArrayExpress reposi-
tories. As far as we know, this issue has not previously
been reported, and the present study provides insight into
precautions that should be taken when using public data.
As our data set is focused on ‘normal’ samples (e.g. no
drug treatments, no gene knock-outs), which are more
likely to be reused as control samples in different experi-
ments, our result that 13.6% of Affymetrix data content
is duplicated might represent an upper boundary; but it
remains clear that a large proportion of these public data
are redundant, and that precautions should be taken when
performing meta-analyses on them.
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We have not identified such problems with RNA-Seq
data so far, but our data set is much smaller, as this data
type was added into Bgee recently (Bgee release 12), and
includes for now only 33 samples from one experiment (23),
composed of 39 runs. Similar issues are likely to appear for
RNA-Seq in the future.
By removing duplicated content from our database and
by correcting annotations inconsistencies between identical
samples, Bgee provides now what we believe to be a
unique data set of duplicate-free, high quality Affymetrix
data. This will enable us to prevent such problems from
appearing in our growing RNA-Seq data set.
All Bgee data are freely available from our website
(http://bgee.unil.ch/).
Supplementary Data
Supplementary data are available at Database Online.
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